These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38261266)

  • 1. Pharmacogenetic study of CES1 gene and enalapril efficacy.
    Hussain M; Basheer S; Khalil A; Haider QUA; Saeed H; Faizan M
    J Appl Genet; 2024 Sep; 65(3):463-471. PubMed ID: 38261266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Functional Assessment of Carboxylesterase 1 Nonsynonymous Polymorphisms.
    Wang X; Rida N; Shi J; Wu AH; Bleske BE; Zhu HJ
    Drug Metab Dispos; 2017 Nov; 45(11):1149-1155. PubMed ID: 28838926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CES1 genetic variation on enalapril steady-state pharmacokinetics and pharmacodynamics in healthy subjects.
    Her LH; Wang X; Shi J; Choi HJ; Jung SM; Smith LS; Wu AH; Bleske BE; Zhu HJ
    Br J Clin Pharmacol; 2021 Dec; 87(12):4691-4700. PubMed ID: 33963573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril.
    Tarkiainen EK; Tornio A; Holmberg MT; Launiainen T; Neuvonen PJ; Backman JT; Niemi M
    Br J Clin Pharmacol; 2015 Nov; 80(5):1131-8. PubMed ID: 25919042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pharmacokinetics of Enalapril in Relation to CES1 Genotype in Healthy Danish Volunteers.
    Stage C; Jürgens G; Guski LS; Thomsen R; Bjerre D; Ferrero-Miliani L; Lyauk YK; Rasmussen HB; Dalhoff K;
    Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):487-492. PubMed ID: 28639420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Influence of Structural Variants of the
    Ikonnikova A; Kazakov R; Rodina T; Dmitriev A; Melnikov E; Zasedatelev A; Nasedkina T
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of the
    Ikonnikova A; Rodina T; Dmitriev A; Melnikov E; Kazakov R; Nasedkina T
    J Pers Med; 2022 Apr; 12(4):. PubMed ID: 35455696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors.
    Wang X; Wang G; Shi J; Aa J; Comas R; Liang Y; Zhu HJ
    Pharmacogenomics J; 2016 Jun; 16(3):220-30. PubMed ID: 26076923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors.
    Thomsen R; Rasmussen HB; Linnet K;
    Drug Metab Dispos; 2014 Jan; 42(1):126-33. PubMed ID: 24141856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators.
    Her L; Zhu HJ
    Drug Metab Dispos; 2020 Mar; 48(3):230-244. PubMed ID: 31871135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender.
    Shi J; Wang X; Nguyen JH; Bleske BE; Liang Y; Liu L; Zhu HJ
    Biochem Pharmacol; 2016 Nov; 119():76-84. PubMed ID: 27614009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CES1P1 variant -816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril.
    Zhu HJ; Langaee TY; Gong Y; Wang X; Pepine CJ; Cooper-DeHoff RM; Johnson JA; Markowitz JS
    Eur J Clin Pharmacol; 2016 Jun; 72(6):681-7. PubMed ID: 26915813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of carboxylesterase 1 genetic polymorphism on trandolapril activation in human liver and the pharmacokinetics and pharmacodynamics in healthy volunteers.
    Wang X; Her L; Xiao J; Shi J; Wu AH; Bleske BE; Zhu HJ
    Clin Transl Sci; 2021 Jul; 14(4):1380-1389. PubMed ID: 33660934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic Polymorphisms.
    Shi J; Wang X; Eyler RF; Liang Y; Liu L; Mueller BA; Zhu HJ
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):555-561. PubMed ID: 27228223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sacubitril Is Selectively Activated by Carboxylesterase 1 (CES1) in the Liver and the Activation Is Affected by CES1 Genetic Variation.
    Shi J; Wang X; Nguyen J; Wu AH; Bleske BE; Zhu HJ
    Drug Metab Dispos; 2016 Apr; 44(4):554-9. PubMed ID: 26817948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.
    Merali Z; Ross S; Paré G
    Drug Metabol Drug Interact; 2014; 29(3):143-51. PubMed ID: 24988246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reappraisal of the genetic diversity and pharmacogenetic assessment of CES1.
    Ferrero-Miliani L; Bjerre D; Stage C; Madsen MB; Jűrgens G; Dalhoff KP; Rasmussen HB
    Pharmacogenomics; 2017 Aug; 18(13):1241-1257. PubMed ID: 28786738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of genetic variation in carboxylesterase drug metabolism.
    Chen F; Zhang B; Parker RB; Laizure SC
    Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):131-142. PubMed ID: 29264996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation.
    Zhu HJ; Wang X; Gawronski BE; Brinda BJ; Angiolillo DJ; Markowitz JS
    J Pharmacol Exp Ther; 2013 Mar; 344(3):665-72. PubMed ID: 23275066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Study of Carboxylesterase 1 Protein Isoforms.
    Wang X; Shi J; Zhu HJ
    Proteomics; 2019 Feb; 19(4):e1800288. PubMed ID: 30520264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.